These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1692388)

  • 1. [Comparative evaluation of radiotherapy and chemoradiotherapy in inoperable cancer of the esophagus].
    Aliev BM; Khydyrov KhB; Kondrat'eva NF
    Med Radiol (Mosk); 1990 Apr; 35(4):24-7. PubMed ID: 1692388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The combined radio-chemotherapy of inoperable esophageal cancer].
    Köhler AH
    Radiobiol Radiother (Berl); 1990; 31(6):497-502. PubMed ID: 1714081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of cytostatics and radiation--a new trend in the treatment of inoperable esophageal cancer.
    Kolarić K
    Prog Clin Biol Res; 1985; 201():259-82. PubMed ID: 2419919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy alone and in combination with bleomycin and 5-fluorouracil in advanced carcinoma esophagus.
    Hukku S; Fernandes P; Vasishta S; Sharma VK
    Indian J Cancer; 1989 Sep; 26(3):131-6. PubMed ID: 2483556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer].
    Zhou JC
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):291-4. PubMed ID: 1725280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inoperable cancer of the esophagus: preliminary results of combined chemotherapy (5-fluorouracil-cisplatin) and radiotherapy].
    Seitz JF; Padaut-Cesana J; Fuentes P; Giudicelli R; Giovannini M; Gauthier A; Reboud E
    Gastroenterol Clin Biol; 1988 Oct; 12(10):736-42. PubMed ID: 3065123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of radiation and chemoradiation therapy in esophageal cancer].
    Azhigaliev NA; Kusherbaev SK; Sadykov SS; Asanov AA; Fel'dman SZ
    Med Radiol (Mosk); 1990 Jun; 35(6):20-3. PubMed ID: 1694002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemoradiotherapy in esophageal cancer].
    Cordiano C; Laterza E; Urso SU; Castaldini G
    Chir Ital; 1994; 46(3):11-5. PubMed ID: 8001187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
    Taieb S; Vaillant E; Pommier P; Bonvoisin S; Desseigne F; Morignat E; Gerard JP; Mornex F
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1048-54. PubMed ID: 10592877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined radiotherapy and chemotherapy (cisplatin, methotrexate, and peplomycin) in esophageal cancer].
    Kagami Y; Sakurai T; Nishio M; Narimatsu N; Saitoh A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Sep; 48(9):1172-6. PubMed ID: 2462208
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy].
    Yasuda T; Yano M; Takiguchi S; Kimura Y; Fujiwara Y; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1737-40. PubMed ID: 14619507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-pathological studies on the effects of preoperative hyperthermo-chemoradiotherapy of advanced esophageal carcinoma].
    Nakamura T; Ide H; Eguchi R; Nogami A; Endo T; Hanashi T; Kubota N; Hayashi K; Yoshida K; Hanyu F
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2573-9. PubMed ID: 1720945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
    Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M; Ohtsu A; Hironaka S; Boku N; Ishikura S; Miyata Y; Ogino T; Yoshida S
    Jpn J Clin Oncol; 2005 Jun; 35(6):316-23. PubMed ID: 15961436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.